tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

QLGN Stock Latest News

3 Penny Stocks to Watch Now, 7/16/24
Market News3 Penny Stocks to Watch Now, 7/16/24
3d ago
MAXN
QLGN
Qualigen Therapeutics Secures Loan and Adjusts Board Structure
PremiumCompany Announcements
Qualigen Therapeutics Secures Loan and Adjusts Board Structure
3d ago
8K
QLGN
Qualigen Therapeutics Secures Loan and Expands Equity
PremiumCompany Announcements
Qualigen Therapeutics Secures Loan and Expands Equity
7d ago
8K
QLGN
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
PremiumPress Releases
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
2M ago
QLGN
Qualigen Therapeutics, Marizyme enter co-development agreement for DuraGraft
PremiumThe Fly
Qualigen Therapeutics, Marizyme enter co-development agreement for DuraGraft
3M ago
QLGN
Qualigen Therapeutics announces presentation on Pan-RAS Inhibitors
PremiumThe FlyQualigen Therapeutics announces presentation on Pan-RAS Inhibitors
3M ago
QLGN
Qualigen Therapeutics’ Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
PremiumPress Releases
Qualigen Therapeutics’ Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
3M ago
QLGN
Qualigen announces AACR poster featuring early clinical experience with QN-302
PremiumThe Fly
Qualigen announces AACR poster featuring early clinical experience with QN-302
3M ago
QLGN
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
PremiumPress Releases
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
3M ago
QLGN
Qualigen Therapeutics Ends Deal with Pan-RAS Holdings
PremiumCompany Announcements
Qualigen Therapeutics Ends Deal with Pan-RAS Holdings
4M ago
8K
QLGN
Qualigen Therapeutics Secures Investment and Expands Financing Options
PremiumCompany Announcements
Qualigen Therapeutics Secures Investment and Expands Financing Options
5M ago
8K
QLGN
Qualigen Therapeutics Inks Exclusive RAS Program Deal
PremiumCompany Announcements
Qualigen Therapeutics Inks Exclusive RAS Program Deal
5M ago
8K
QLGN
Qualigen Therapeutics Inc (QLGN) Q3 Earnings Cheat Sheet
PremiumPre-EarningsQualigen Therapeutics Inc (QLGN) Q3 Earnings Cheat Sheet
8M ago
QLGN
Qualigen Therapeutics announces first patient dosed in Phase 1a trial of QN-302
PremiumThe Fly
Qualigen Therapeutics announces first patient dosed in Phase 1a trial of QN-302
8M ago
QLGN
Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
PremiumPress Releases
Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
8M ago
QLGN
Poster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer
PremiumPress Releases
Poster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer
9M ago
QLGN
Qualigen Therapeutics announces poster highlighting Pan-RAS inhibitor platform
PremiumThe Fly
Qualigen Therapeutics announces poster highlighting Pan-RAS inhibitor platform
9M ago
QLGN
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
PremiumPress Releases
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
10M ago
QLGN
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
PremiumPress Releases
Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023
10M ago
QLGN
Qualigen Therapeutics presents scientific data on QN-302 at AACR conference
PremiumThe FlyQualigen Therapeutics presents scientific data on QN-302 at AACR conference
10M ago
QLGN
Qualigen Therapeutics partners with TD2 for Phase 1 development of QN-302
PremiumThe Fly
Qualigen Therapeutics partners with TD2 for Phase 1 development of QN-302
11M ago
QLGN
Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors
PremiumPress Releases
Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors
11M ago
QLGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >